AbbVie – Pharmaceutical Research & Development. AbbVie Products List

Our products are approved in individual countries for specific uses and the information provided is governed by local regulations.

Product availability, name and indicated use may vary by country. Please contact your local AbbVie office to learn more about products available in your country.

Not all products may be listed. This list may be updated at any time. Always ask a healthcare professional for advice about medicines.

Immunology AbbVie

  • HUMIRA® (adalimumab) injection, for subcutaneous use
  • RINVOQ™ (upadacitinib) extended-release tablets for oral use
  • SKYRIZI® (risankizumab-rzaa) injection, for subcutaneous use

Neuroscience AbbVie

  • BOTOX® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use
  • CELEXA® (citalopram hydrobromide) tablets
  • DEPAKOTE® (divalproex sodium) delayed-release tablets, for oral use
  • DEPAKOTE® ER (divalproex sodium) extended-release tablets, for oral use
  • DEPAKOTE® SPRINKLE CAPSULES (divalproex sodium) delayed release capsules, for oral use
  • DUOPA (carbidopa and levodopa) enteral suspension
  • FETZIMA® (levomilnacipran) extended-release capsules, for oral use
  • FIORINAL® (Butalbital, Aspirin, and Caffeine Capsules, USP), CIII
  • FIORINAL® WITH CODEINE (butalbital, aspirin, caffeine, and codeine phosphate) capsules, for oral use, CIII
  • LEXAPRO® (escitalopram oxalate) oral solution(escitalopram oxalate) tablets, for oral use
  • NAMENDA XR® (memantine hydrochloride) extended release capsules, for oral use
  • NAMENDA® (memantine HCl) tablets, for oral use
  • NAMZARIC® (memantine and donepezil hydrochlorides) extended-release capsules, for oral use
  • QULIPTA™ (atogepant) tablets, for oral use
  • SAPHRIS® (asenapine) sublingual tablets
  • SAVELLA® (milnacipran HCl) tablets
  • UBRELVY™ (ubrogepant) tablets, for oral use
  • VIIBRYD® (vilazodone hydrochloride) tablets, for oral use
  • VRAYLAR® (cariprazine) capsules, for oral use

Oncology AbbVie

  • VENCLEXTA® (venetoclax tablets), for oral use

Virology AbbVie

  • KALETRA® (lopinavir/ritonavir) tablets, for oral use and oral solution
  • MAVYRET® (glecaprevir/pibrentasvir) tablets, for oral use
  • NORVIR® (ritonavir) tablets, for oral use and oral solution and oral powder
  • VIEKIRA PAK® (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets), co-packaged for oral use

Other Specialty Areas AbbVie

  • ACTONEL® (risedronate sodium) tablets, for oral use
  • AEROCHAMBER PLUS® FLOW-VU® Anti-Static Valved Holding Chamber Small Mask/Medium MaskAnti-Static Valved Holding Chamber Mouthpiece/Large Mask
  • ALORA® (estradiol transdermal system)
  • ANDRODERM® (testosterone transdermal system), for topical use CIII
  • ANDROGEL® (testosterone gel) 1.62%
  • AQUADEKS® chewable tablets (aqua-dex’) multivitamin and mineral supplement
  • ARMOUR® THYROID (thyroid tablets, USP) ATELVIA® (risedronate sodium) delayed-release tablets
  • AVAGE® (tazarotene) cream 0.1%, for topical use
  • AVYCAZ® (ceftazidime and avibactam) for injection, for intravenous use
  • BYSTOLIC® (nebivolol) tablets, for oral use
  • CONDYLOX® Gel 0.5% (podofilox gel)
  • CREON® (pancrelipase) Delayed-Release Capsules for oral use
  • CRINONE® (progesterone gel), for vaginal use
  • DALVANCE® (dalbavancin) for injection, for intravenous use
  • ENABLEX® (darifenacin) extended-release tablets
  • ESTRACE® Cream (estradiol vaginal cream, USP, 0.01%)
  • ESTROSTEP® FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets)
  • FEMHRT® (norethindrone acetate/ethinyl estradiol tablets)
  • FLUTTER® Mucus Clearance Device
  • GELNIQUE® (oxybutynin chloride) 10% gel
  • GENERESS® FE (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets)
  • GENGRAF® Capsules (cyclosporine capsules, USP [modified])
  • GENGRAF® Oral Solution (cyclosporine oral solution, USP [modified])
  • INFED® (iron dextran Injection USP)
  • K-TAB® (potassium chloride) extended-release tablets, for oral use
  • KADIAN® (morphine sulfate) extended-release capsules, for oral use, CII
  • LILETTA® (levonorgestrel-releasing intrauterine system) SHI
  • LO LOESTRIN® FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets)
  • LUPANETA PACK® (leuprolide acetate for depot suspension and norethindrone acetate tablets), co-packaged for intramuscular use and for oral use, respectively
  • LUPRON DEPOT-PED® (leuprolide acetate for depot suspension)
  • LUPRON DEPOT® GYN (leuprolide acetate for depot suspension)
  • LUPRON DEPOT® URO (leuprolide acetate for depot suspension)
  • MINASTRIN® 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets)
  • MONUROL® (fosfomycin tromethamine) granules for oral solution
  • NEPHRO-VITE®RX (vitamin B complex and C supplement)
  • NIASPAN® (niacin extended-release tablets) for oral use
  • NIMBEX® (cisatracurium besylate) injection, for intravenous use
  • NORCO® (hydrocodone bitartrate and acetaminophen tablets, USP) CII
  • ORIAHNN® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) co-packaged for oral use
  • ORILISSA® (elagolix) tablets, for oral use
  • OXYTROL® (oxybutynin transdermal system)
  • RAPAFLO® (silodosin) capsules, for oral use
  • RECTIV® (nitroglycerin) ointment 0.4%, for intra-anal use
  • SURVANTA® (beractant) intratracheal suspension
  • SYNTHROID® (levothyroxine sodium) tablets, for oral use
  • TARKA® (trandolapril/verapamil HCI ER tablets)
  • TAYTULLA® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), for oral use
  • TEFLARO® (ceftaroline fosamil) for injection, for intravenous use
  • THYROLAR® Tablets (liotrix tablets, USP)
  • TRICOR® (fenofibrate) tablets, for oral use
  • TRILIPIX® (fenofibric acid) delayed-release capsules
  • ULTANE® (sevoflurane) volatile liquid for inhalation
  • VANIQA® (eflornithine hydrochloride) cream, 13.9%
  • ZEMPLAR® (paricalcitol) injection(paricalcitol) capsules, for oral use

Gastroenterology AbbVie

  • ACTIGALL® (ursodiol, USP) capsules
  • ASACOL® HD (mesalamine) delayed-release tablets, for oral use
  • BENTYL® (dicyclomine hydrochloride) injection, for intramuscular use
  • CANASA® (mesalamine) rectal suppository
  • CARAFATE® (sucralfate) tablets(sucralfate) suspension
  • DELZICOL® (mesalamine) delayed-release capsules, for oral use
  • LINZESS® (linaclotide) capsules, for oral use
  • PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules, for oral use
  • URSO 250® and URSO FORTE® (ursodiol) tablets, for oral use
  • VIBERZI® (eluxadoline) tablets, for oral use, CIV

Eye Care AbbVie

  • ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4%
  • ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5%
  • ACUVAIL® (ketorolac tromethamine ophthalmic solution) 0.45%
  • ALOCRIL® (nedocromil sodium ophthalmic solution) 2%
  • ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%
  • BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5%
  • BLEPHAMIDE® (sulfacetamide sodium − prednisolone acetate ophthalmic suspension, USP) 10%/0.2%(sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2%
  • BLEPH®-10 (sulfacetamide sodium ophthalmic solution, USP) 10%
  • COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
  • DURYSTA™ (bimatoprost implant) for intracameral administration
  • FML FORTE® (fluorometholone ophthalmic suspension) 0.25%
  • FML® (fluorometholone ophthalmic ointment) 0.1%(fluorometholone ophthalmic suspension, USP) 0.1%
  • LASTACAFT® (alcaftadine ophthalmic solution) 0.25%, for topical ophthalmic use
  • LUMIGAN® (bimatoprost ophthalmic solution) 0.01%, for topical ophthalmic use
  • OCUFLOX® (ofloxacin ophthalmic solution) 0.3%
  • OZURDEX® (dexamethasone intravitreal implant) for intravitreal injection
  • POLYTRIM® (polymyxin B sulfate and trimethoprim ophthalmic solution, USP)
  • PRED FORTE® (prednisolone acetate ophthalmic suspension, USP) 1%
  • PRED-G® (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3% / 0.6%(gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3% / 1%
  • Portfolio of Consumer Eye Care Products
  • RESTASIS MULTIDOSE® (cyclosporine ophthalmic emulsion) 0.05%
  • RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%
  • VUITY™ (pilocarpine HCl ophthalmic solution) 1.25%
  • XEN®
  • ZYMAXID® (gatifloxacin ophthalmic solution) 0.5%, for topical ophthalmic use

Medical Aesthetics AbbVie

  • ALLODERM SELECT RESTORE™ Regenerative Tissue Matrix
  • ALLODERM SELECT™ Regenerative Tissue Matrix
  • ALLODERM™ Regenerative Tissue Matrix
  • ARTIA™ Reconstructive Tissue Matrix
  • BOTOX® Cosmetic (onabotulinumtoxinA)
  • CUI™ Brand
  • JUVÉDERM® Ultra XC,
  • JUVÉDERM® Ultra,
  • JUVÉDERM® Ultra Plus XC,
  • JUVÉDERM® Voluma™ XC,
  • KYBELLA® (deoxycholic acid) injection, for subcutaneous use
  • LATISSE® (bimatoprost ophthalmic solution) 0.03%, for topical ophthalmic use
  • NATRELLE® Breast Implant Sizers, NATRELLE® Breast Implants, NATRELLE® 133 Tissue Expander
  • REVOLVE ENVI™ 600 Advanced Adipose System
  • REVOLVE™ Advanced Adipose System
  • STRATTICE™ BPS Reconstructive Tissue Matrix,
  • STRATTICE™ Reconstructive Tissue Matrix Perforated,
  • STRATTICE™ Reconstructive Tissue Matrix Extra Thick,
  • STRATTICE™ Reconstructive Tissue Matrix Laparoscopic,
  • STRATTICE™ Reconstructive Tissue Matrix

AbbVie Pharmaceutical Research & Development AbbVie site

Name : AbbVie Inc

Contact Details AbbVie Inc –

Country : U.S.A.
Sity : Illinois. North Chicago
postalCode :
Street :
Telephone : 1-800-FDA-1088
E-mail :